Peanut Allergy Patch Works Long-Term, Says Drugmaker

<![CDATA[]]>(MedPage Today) — DBV Technologies said its investigational topical treatment for peanut allergy in children showed continued benefit in an extension of its main phase III trial, which the company hopes will lead to marketing approval later this…

Source link

Related posts

Mothers whose responses to infants' facial cues increase report stronger bonds with babies


Gangrenous Necrotizing Cutaneous Mucormycosis in an Immunocompetent Neonate: A Case Report from Oman


No evidence tougher policies deter adolescent cannabis use


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy